Groupe la Francaise’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,461
Closed -$3.63M 516
2026
Q1
$3.63M Sell
6,461
-666
-9% -$427K 0.05% 229
2025
Q4
$4.82M Sell
7,127
-638
-8% -$434K 0.07% 182
2025
Q3
$4.96M Sell
7,765
-130
-2% -$78.9K 0.07% 165
2025
Q2
$4.22M Buy
7,895
+1,349
+21% +$645K 0.07% 161
2025
Q1
$2.77M Buy
6,546
+734
+13% +$319K 0.06% 204
2024
Q4
$2.4M Buy
+5,812
New +$2.55M 0.06% 174

Other funds holding IDXX

Groupe la Francaise's IDXX Position: Q2 2026 in Review

Groupe la Francaise sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 6,461 shares — an estimated $3.63M sold.

Groupe la Francaise first reported a position in IDXX in Q4 2024 and held it in 6 quarters. The position peaked at $4.96M in Q3 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Groupe la Francaise reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Groupe la Francaise sold 6,461 Idexx Laboratories shares in Q2 2026, an estimated $3.63M.
  • Groupe la Francaise first reported a position in Idexx Laboratories in Q4 2024 and held it in 6 quarters.
  • Groupe la Francaise's Idexx Laboratories position peaked at $4.96M in Q3 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.